Connect with us

Business

Novavax vaccine 90 per cent effective – PerthNow

Data from its US clinical trial shows this new vaccine is more than 90 per cent effective against COVID-19, and it could be in…

Published

on

Article feature image

Novavax Inc has reported late-stage data from its US-based clinical trial showing its vaccine is more than 90 per cent effective against COVID-19 across a variety of variants of the virus.
The study of nearly 30,000 volunteers in the United States and Mexico…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Marley Spoon (ASX:MMM) share price on watch after mixed Q2 update
Race Oncology (ASX:RAC) share price slumps on quarterly update